These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 10785771)

  • 1. Eptifibatide and tirofiban: new preparations. Limited benefit.
    Prescrire Int; 2000 Oct; 9(49):135-8. PubMed ID: 11603412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina.
    Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F
    Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unstable angina: individualized stratification and prognosis.
    Trinca M; Dionísio P; Araújo FV; Soares R; Vasconcelos J; Caeiro A; Jara A
    Rev Port Cardiol; 2000 May; 19(5):567-78. PubMed ID: 10916430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors predictive of unstable angina resulting from restenosis after percutaneous angioplasty of saphenous vein grafts.
    Chandrasekar B; Bourassa MG
    Am Heart J; 2000 Dec; 140(6):827-33. PubMed ID: 11099984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study).
    Michalis LK; Stroumbis CS; Pappas K; Sourla E; Niokou D; Goudevenos JA; Siogas C; Sideris DA
    Eur Heart J; 2000 Dec; 21(23):1954-9. PubMed ID: 11071801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina? An observational study of myocardial ischaemia and its relation to coronary anatomy.
    Patel DJ; Gomma AH; Knight CJ; Mulcahy DA; Wright CA; Purcell HJ; Fox KM
    Eur Heart J; 2001 Nov; 22(21):1991-6. PubMed ID: 11603906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coronary angioplasty. Initial experience of the Santa Cruz Hospital].
    Seabra-Gomes R; Silva JM; Aleixo A; Real T; Rebocho MJ
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-73-6. PubMed ID: 11515303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distal protection with a filter device during coronary stenting in patients with stable and unstable angina.
    Angelini A; Rubartelli P; Mistrorigo F; Della Barbera M; Abbadessa F; Vischi M; Thiene G; Chierchia S
    Circulation; 2004 Aug; 110(5):515-21. PubMed ID: 15277328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of slow flow phenomenon during primary stenting by bail-out administration of abciximab.
    Kaul U; Sapra R; Singh B; Sudan D; Ghose T; Dixit NS; Wasir HS
    Int J Cardiovasc Intervent; 2000 Mar; 3(1):35-39. PubMed ID: 12470385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-EffectiveUtilization of Abciximab During Coronary Angioplasty in the Setting of Unstable Angina: A Case Study.
    Muhlestein JB
    J Invasive Cardiol; 1996; 8 Suppl B():48B-50B. PubMed ID: 10785771
    [No Abstract]   [Full Text] [Related]  

  • 12. Abciximab and percutaneous coronary intervention: new indications. Medium-term benefit.
    Prescrire Int; 2000 Apr; 9(46):36-8. PubMed ID: 11503782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute severe thrombocytopenia after c7E3 Fab (abciximab) therapy in a patient with unstable angina and stenting of the right coronary artery. Occurrence of subacute stent thrombosis and safe readministration of the GPIIb/IIIa inhibitor tirofiban.
    Simon BC; Herzum M; Klisch A; Schürmann M; Zeiler T; Kretschmer V; Maisch B
    Int J Cardiovasc Intervent; 2000 Sep; 3(3):185-188. PubMed ID: 12470370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating cost-effectiveness evidence into clinical practice guidelines in Australia for acute myocardial infarction.
    Antioch KM; Jennings G; Botti M; Chapman R; Wulfsohn V
    Eur J Health Econ; 2002; 3(1):26-39. PubMed ID: 15609115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group.
    Price DJ; Campbell PG; Sutton AG; Grech ED; Davies A; Hall JA; De Belder MA
    Int J Cardiovasc Intervent; 2001 Mar; 4(1):15-20. PubMed ID: 12431335
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.